Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04002
Species: Homo sapiens
Position : chr14:76419740-76421740
Year: 2019
Title: Targeting FOXA1-mediated repression of TGF-汕 signaling suppresses castration-resistant prostate cancer progression.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: prostate cancer
PMID:  30511964
MONDO: MONDO:0008315
Tissue: prostate gland
Tissue Ontology ID: UBERON:0002367
Cell Source: LNCaP
CVCL ID: CVCL_0395
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: TF-binding/chromatin assay; Endogenous enhancer perturbation; In vivo functional validation; Disease-associated enhancer analysis
High Throughput Method: ChIP-seq
Low Throughput Method: CRISPR-Cas9 targeted editing/deletion; ChIP-qPCR/ChIP; RT-qPCR/qPCR
About Target Gene
Target gene : TGFB3
About TF
TF name : FOXA1
About Regulatory State
Regulatory State : Repressed
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOXA1 AndrogenReceptor netpath 167
FOXA1 Direct p53 effectors pid 141
FOXA1 FOXA1 transcription factor network pid 45
FOXA1 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer